FDA Clears QIAGEN’s Rapid QIAstat-Dx Panel for Meningitis and Encephalitis Diagnosis, Expanding Syndromic Test Portfolio

(IN BRIEF) QIAGEN’s QIAstat-Dx Meningitis/Encephalitis Panel has received FDA clearance, enabling faster and more accurate diagnosis of critical CNS infections like meningitis and encephalitis. This panel, the fourth QIAstat-Dx test approved in the U.S. in 2024, uses real-time PCR to … Read the full press release →